The Pragmatic MBA for Scientific and Technical Executives

Erscheinungsjahr 2012
ISBN: 978-0-12-397932-2
Verlag: Elsevier Health Sciences

Buch, Englisch, 176 Seiten, Format (B × H): 153 mm x 236 mm, Gewicht: 427 g

This primer enables professionals with technical expertise to collaborate with their business-side colleagues. Emphasizing brevity and clarity, it gives technical staff answers to their most pressing questions about economics, finance, marketing, strategic decision-making, accounting, management, and related subjects. It does not offer condensed 1st year MBA courses; instead, it presents streamlined concepts and insights that are easy enough to be accessible and challenging enough to hold one's interest. Its examples from pharma, IT, aircraft/navigation, and other industries highlight problems that technical professionals face daily. Written by "one of them," its credibility makes it more useful than Internet resources. Because it concentrates on pragmatic (as opposed to academic) approaches to business, it empowers technical staff to stay with the conversation--and take it to a higher level.

Bertrand C. Liang, MD, PhD, MBA, is Managing Director of LCC Ventures and Executive Director of Pfenex, Inc. He is trained in molecular biology and genetics (PhD) and is a clinician (MD) with subspecialty training in neurology and oncology, and serves as a Visiting University Professor at Liaoning He University, Shenyang, China.

Zielgruppe

Professionals in technical industries, especially pharma, IT, and aircraft/navigation, 1st year MBA students with technical backgrounds, and participants in executive MBA courses, especially those from technical industries.

Autoren/Hrsg.

Liang, Bertrand C

Fachgebiete

• Technische Wissenschaften Technik Allgemein Betriebswirtschaft für Ingenieure

Inhaltsverzeichnis

1. Marketing2. Economics3. Strategy4. Management and Leadership5. Portfolio Management6. Finance and Accounting7. Operations

Über Autor(innen)

Liang, Bertrand C
Bert Liang is trained in molecular biology and genetics (Ph.D.) and is a clinician (M.D.) with subspecialty training in both neurology and oncology. He possesses an MBA as well as corporate experience (currently Executive Director of Pfenex Inc.) and has more than 50 publications in both scientific and business subjects.